Work

Pulmonary Cellular Toxicity in Alpha-1 Antitrypsin Deficiency

Year: 2024

Type: article

Abstract: production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Source: CHEST Journal

DOI: 10.1016/j.chest.2024.02.013

Authors: Kristine M. Abo, Carly Merritt, Maria C. Basil, Susan M. Lin, Edward Cantu, Michael P. Morley, Pushpinder Bawa, Marissa Gallagher, Derek E. Byers, Edward E. Morrisey, Andrew A. Wilson

Institutions: Boston University, Boston Medical Center, University of Pennsylvania, Washington University in St. Louis

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,790

Funders: U.S. Department of Defense, Alpha-1 Foundation, Arthur Ashley Williams Foundation, United Therapeutics Corporation, Boston University, CSL Behring, CareDx, Grifols, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: G1170118127, G1638758988, G1933960382, G1945775778, Personalized therapy for AATD-associated liver disease via IPS modeling, PRECLINICAL DEVELOPMENT OF A NEW KINASE INHIBITOR FOR POSTVIRAL LUNG DISEASE, Circadian Signatures in Chronic Lung Disease, PRECLINICAL DEVELOPMENT OF A NEW KINASE INHIBITOR FOR COPD, G6655870208, G9000097463, G9000144401, G9000177000, G9000223412, G9000241413, G9000335720, Institutional Career Development Core, Developing Pluripotent Stem Cells to Model and Treat Lung Disease, Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH)

OpenAlex ID: W4391818241

FWCI: 1.773

Cites: 30

Cited by: 7

Related to: 10